<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Temodar from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Temodar news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 06:57:16 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Temodar" rel="self" type="application/rss+xml" />

	
<item><title>Court Rules In Favor Of Teva In Temodar Patent Litigation - Quick Facts</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3988155&amp;HITNO=0&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3988155&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2510590591%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3988155&amp;HITNO=0&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3988155&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2510590591%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Quote.com Japan:</description></item>
<item><title>Schering's Temodar Patent Ruled To Be Unenforceable</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3986313&amp;HITNO=1&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3986313&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2509088972%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3986313&amp;HITNO=1&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3986313&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2509088972%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Law360:</description></item>
<item><title>Prosecution Laches and Inequitable Conduct: Cancer Research Tech. v Barr Labs</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3987977&amp;HITNO=2&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3987977&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2510319264%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3987977&amp;HITNO=2&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3987977&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2510319264%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Patent Baristas:</description></item>
<item><title>U.S. District Court Rules Against Merck in TEMODAR (temozolomide) Patent Lawsuit</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3981428&amp;HITNO=3&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3981428&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2506985056%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3981428&amp;HITNO=3&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3981428&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2506985056%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PharmiWeb:</description></item>
<item><title>News and FDA Updates for OncoVista (OTC:OVIT), Teva (Nasdaq:TEVA), ZIOPHARM (Nasdaq:ZIOP)</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3984851&amp;HITNO=4&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3984851&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508382812%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3984851&amp;HITNO=4&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3984851&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508382812%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Los Angeles Chronicle:</description></item>
<item><title>Teva wins brain cancer drug challenge</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3984402&amp;HITNO=5&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3984402&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508151184%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3984402&amp;HITNO=5&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3984402&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2508151184%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>IP World Online:</description></item>
<item><title>News and FDA Updates for OncoVista (OTC:OVIT), Teva (Nasdaq:TEVA), ZIOPHARM (Nasdaq:ZIOP)</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3980688&amp;HITNO=6&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3980688&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2506520807%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3980688&amp;HITNO=6&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3980688&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2506520807%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>American Chronicle:</description></item>
<item><title>News and FDA Updates for OncoVista (OTC:OVIT), Teva (Nasdaq:TEVA), ZIOPHARM (Nasdaq:ZIOP)</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3980314&amp;HITNO=7&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3980314&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2506321859%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3980314&amp;HITNO=7&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3980314&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2506321859%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>California Chronicle:</description></item>
<item><title>Merck to appeal as judge backs Teva over generic Temodar</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3974588&amp;HITNO=8&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3974588&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2503597584%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3974588&amp;HITNO=8&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3974588&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2503597584%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Times:</description></item>
<item><title>US District Court rules against Merck in TEMODAR patent lawsuit</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3977962&amp;HITNO=9&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3977962&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2505038711%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3977962&amp;HITNO=9&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3977962&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2505038711%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharmacy Choice:</description></item>
<item><title>Teva Moves Ahead in Brain Drug Battle</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3978719&amp;HITNO=10&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3978719&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2505434598%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3978719&amp;HITNO=10&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3978719&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2505434598%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Cafepharma:</description></item>
<item><title>U.S. District Court rules against Merck in Temodar (temozolomide) patent lawsuit</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3977896&amp;HITNO=11&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3977896&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2505005617%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3977896&amp;HITNO=11&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3977896&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2505005617%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>HemOnc Town:</description></item>
<item><title>Teva Receives Favorable Court Decision Regarding Generic Temodar(R)</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3973191&amp;HITNO=12&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3973191&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2502791402%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3973191&amp;HITNO=12&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3973191&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2502791402%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>MediLexicon:</description></item>
<item><title>Teva obtains favorable court decision for generic brain cancer drug</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3979124&amp;HITNO=13&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3979124&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2505657425%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3979124&amp;HITNO=13&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3979124&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2505657425%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Therapeutics Daily:</description></item>
<item><title>Teva obtains favorable court decision for generic brain cancer dr...</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3976371&amp;HITNO=14&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3976371&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2504361184%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3976371&amp;HITNO=14&amp;MSIZE=101&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Temodar&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3976371&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2504361184%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Zibb:</description></item>
</channel></rss>